Clinical Trial Update: Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase III trial comparing Gemcitabine, TS-1, and Gemcitabine plus TS-1 in pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)
• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Pancreatic Cancer | Phase 3 | Status: COMPLETED